Israel Englander’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Sell
1,054,705
-1,216,872
-54% -$2.23M ﹤0.01% 3759
2026
Q1
$4.07M Buy
2,271,577
+437,041
+24% +$927K ﹤0.01% 3177
2025
Q4
$4.11M Sell
1,834,536
-121,842
-6% -$320K ﹤0.01% 3223
2025
Q3
$4.73M Buy
+1,956,378
New +$5.21M ﹤0.01% 3206
2024
Q3
Sell
-91,873
Closed -$226K 6391
2024
Q2
$226K Sell
91,873
-455,042
-83% -$1.22M ﹤0.01% 5070
2024
Q1
$897K Sell
546,915
-91,199
-14% -$134K ﹤0.01% 4389
2023
Q4
$1.14M Buy
638,114
+424,368
+199% +$910K ﹤0.01% 4058
2023
Q3
$979K Buy
+213,746
New +$2.05M ﹤0.01% 4207
2023
Q2
Sell
-102,059
Closed -$1.16M 6567
2023
Q1
$1.16M Buy
+102,059
New +$1.09M ﹤0.01% 3957
2022
Q3
Sell
-1,480,446
Closed -$14.8M 7400
2022
Q2
$14.8M Sell
1,480,446
-331,515
-18% -$3.28M 0.01% 1602
2022
Q1
$17.9M Buy
1,811,961
+439,308
+32% +$4.33M 0.01% 1502
2021
Q4
$13.6M Sell
1,372,653
-95,349
-6% -$943K 0.01% 1815
2021
Q3
$14.4M Sell
1,468,002
-103,167
-7% -$1.02M 0.01% 1627
2021
Q2
$15.9M Buy
+1,571,169
New +$15.9M 0.01% 1420

Other funds holding PROK

Israel Englander's PROK Position: Q2 2026 in Review

Israel Englander reduced its ProKidney (PROK) stake by 54% in Q2 2026, selling an estimated $2.23M and leaving 1,054,705 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3759.

Israel Englander first reported a position in PROK in Q2 2021 and has held it in 14 quarters since. The position peaked at $17.9M in Q1 2022. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Israel Englander held 1,054,705 shares of ProKidney worth $2.15M as of Q2 2026.
  • Israel Englander sold 1,216,872 ProKidney shares in Q2 2026, an estimated $2.23M.
  • ProKidney made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3759 holding.
  • Israel Englander first reported a position in ProKidney in Q2 2021 and has held it in 14 quarters since.
  • Israel Englander's ProKidney position peaked at $17.9M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.